Who We Fund
Since 1949, 青云体育 has provided more than $1.8 billion to the best and the brightest blood cancer researchers and biotech companies to support their groundbreaking research. Meet grantees and the companies who鈥檝e joined our fight to find cures and help blood cancer patients everywhere.
Sisi Chen
leukemia
Jun Qi
Myeloma
Dane Vassiliadis
blood cancer biology
Shazia Nakhoda
Equity in Access
Reina Takeda
AML
Simona Colla
Myeloma biology
Julia Maxson
AML
Justine Kahn
pediatric leukemia and lymphoma
Paul Beavis
immunotherapy in myeloma
Todd Fehniger
NK/CART cell therapy for lymphomas and pediatric AML
Paolo Strati
Non-Hodgkin Lymphoma
Jeetayu Biswas
splicing in myeloid diseases
Jianhua Yu
myeloma immunotherapy
Eugenio Morelli
Myeloma
Hao Jiang
DNA biology and leukemia
Michael Keller
COVID-19, immunotherapy
Stephen Gottschalk
pediatric leukemia and CAR-T
Thomas Kipps
Hairy Cell Leukemia
Christian Marinaccio
MLL leukemias
Nizar Bahlis
Myeloma immunotherapy
Affimed
immunotherapy, HL, PTCL
Leandro Cerchietti
DLBCL
Adam de Smith
pediatric ALL and Down Syndrome
Sigur冒ur Kristinsson
Smoldering myeloma
Megan McNerney
AML/MDS
Enrico Tiacci
Hairy cell leukemia
Xu Ji
Equity in Access
Sergei Doulatov
Leukemias
Kathleen Sakamoto
pediatric AML
Alexey Danilov
lymphoma
Christopher Flowers
clinical trial access
Koichi Takahashi
AML/MDS
Eirini Papapetrou
blood cancer stem cells
Helen Parsons
Equity in Access
Gareth Morgan
smoldering myeloma, MGUS
Jing Yang
Myeloma
Immunitas Therapeutics
immunotherapy, DLBCL, Hodgkin's
Ivan Odak
Non-Hodgkin's Lymphoma immunotherapy
Peter Klein
MDS
Peter Croucher
Multiple Myeloma
Grant Challen
preleukemia, leukemia
Marco Ruella
Immunotherapy for T-cell lymphoma
Courtney Jones
AML metabolism
Randall Davis
CLL
Ricky Johnstone
lymphoma and myeloma
Carl June
CAR T immunotherapy
Nicoletta Cieri
AML and transplantation
Anita Kumar
Mantle Cell Lymphoma immunotherapy
Raymond Mailhot
Equity in Access
Ryvu Therapeutics
AML, MDS, Myelofibrosis
Frederike Kramer
MPNs
Anouchka Laurent
T-cell lymphoma
Bruno Paiva
smoldering myeloma
Daniel Pollyea
AML
Paolo Caimi
CAR-T clinical trial for CLL
Alex Kentsis
pediatric leukemias
Lori Muffly
Equity in Access
Joachim Yahalom
Lymphoma
Wendy B茅guelin
follicular lymphoma
Noem铆 Puig Mor贸n
Myeloma
Ronald Levy
immunotherapies, COVID-19
Rgenta Therapeutics
RNA-targeting, blood cancer
Nataly Cruz-Rodriguez
T-ALL and metabolism
Tanya Siddiqi
clinical trial access
Yoke Seng Lee
AML
Grzegorz Nowakowski
Clinical trial access
Courtney DiNardo
clinical trials, AML
Jeremy Baeten
AML
Vittoria Biotherapeutics
immunotherapy, CAR-T, TCL
Arash Alizadeh
blood cancer biology and diagnosis
Alec Zhang
myeloma, immunotherapy
Jake Shortt
precision therapy for aggressive lymphomas
Ruben Carrasco
Myeloma
Areej El-Jawahri
transplant survivorship
Jenny Wang
AML
Nirav Shah
CAR-T for lymphoma
Rayne Rouce
Immunotherapy for pediatric, adolescent & young adult patients
Matthew Frank
Lymphoma CART therapy
Jonathon Cohen
lymphoma clinical trial access in Georgia
Kimberly Stegmaier
childhood blood cancers
Adam Olszewski
Follicular and marginal zone lymphoma
Britta Will
Leukemia and pre-leukemia
Dimericon Therapeutics
dimericons, blood cancer
Susan Schwab
cancer immunology
Michaela Reagan
Multiple Myeloma
Liling Wan
AML
George Vassiliou
Leukemia Prevention
Marina Konopleva
MDS/AML metabolism
Daniel Herranz
T-ALL
Immune-Onc Therapeutics
immunotherapy, AML, CMML
Bing Carter
p53 mutant AML
Ravindra Majeti
preleukemia, AML
Wendy Stock
T-cell ALL
BioInvent International
immunotherapy, indolent NHL, CTCL
Neha Mehta-Shah
T-cell lymphoma
Tomasz Skorski
myeloproliferative neoplasms, AML
Christian Steidl
B-cell lymphomas
Nitin Jain
CLL
Christopher Porter
Leukemia, lymphoma
Michael Kharas
leukemia
ImCheck Therapeutics
immunotherapy, AML
Stacie Dusetzina
Equity in Access
Mark Murakami
follicular lymphoma
Trent Hall
MDS
Mendel Goldfinger
MDS/AML trials for the elderly
Urvi Shah
Diet and myeloma
Sahand Hormoz
MPN
Sham Mailankody
Myeloma immunotherapy clinical trials
Catherine Bollard
pediatric blood cancers and immunotherapy
Inhye Ahn
CLL
Carl Allen
pediatric blood cancers
John Crispino
myelofibrosis, pediatric leukemia and Downs
Piers Patten
COVID-19
Faron Pharmaceuticals
immunotherapy, MDS
Amit Verma
AML/MDS
Maximilian Stahl
AML immunotherapy
Solu Therapeutics
immunotherapy, CMML
Lawrence Boise
CART and myeloma
Tak Mak
Immunotherapy
Jean Koff
Disparities in DLBCL
Michael Green
lymphoma biology
Fenghuang Zhan
Myeloma and bone disease
Sheng Li
Aging and AML
Jonathan Licht
DNA biology, myeloma
Ramon Massoni-Badosa
CLL and Richter's Syndrome
H. Irene Su
Equity in Access
Lindsey Montefiori
pediatric leukemia
Jaroslaw Maciejewski
bone marrow failure
Ann-Kathrin Eisfeld
Racial diversity in AML
Dan Landau
cancer evolution biology
Riccardo Dalla-Favera
lymphoma (DLBCL)
Catherine Diefenbach
DLBCL immunology
Caron Jacobson
lymphoma and immunotherapy
Jolanta Grembecka
leukemia therapeutics
Gianpietro Dotti
CAR T and AML
Saar Gill
AML immunotherapy
Jane Oliaro
Myeloma & Lymphoma Immunotherapy
Lakshmi Nayak
brain tumors in lymphoma
Ryan Wilcox
T-cell lymphoma
Zachary Epstein-Peterson
Peripheral T-cell lymphoma trial
Nicolas Nassar
pediatric leukemia
Jennifer Trowbridge
aging and leukemia
Craig Jordan
AML
Kasey Leger
pediatric blood cancers
Alison Moskowitz
lymphoma therapeutics
Paola Aguilar Neuville
Primary cutaneous 纬未 T-cell lymphoma
Siddhartha Jaiswal
preleukemia
Caribou Biosciences
immunotherapy, allo-CAR, NHL, MM, AML
Margaret Shipp
lymphoma biology
Robert Soiffer
transplantation
Martin Dreyling
Mantle Cell Lymphoma
Alieen Rowan
Adult T cell leukemia/lymphoma
John Leonard
lymphoma research
Tycel Phillips
Mantle Cell Lymphoma
Qingyu Luo
BPDCN
Yubin Zhou
peripheral T cell lymphoma
William Matsui
Myeloma
James Rubenstein
Lymphoma of the Central Nervous System
Daniel Lucas
bone marrow and leukemia biology
Ari Melnick
epigenetics and lymphoma
Eric Pietras
AML
Ravi Bhatia
transplantation
Rizwan Romee
Immunotherapy
Julia Paczkowska
immunobiology of Hodgkin's disease
Anushree Vichare
Equity in Access
George Daley
"off-the-shelf" CAR-T and CAR-NK
Huda Salman
CMML
Frederick Locke
lymphoma and immunotherapy
Yiman Liu
Epigenetics and leukemia
Mala Shanmugam
myeloma
Soheil Meshinchi
pediatric AML
Stephen Nimer
myeloid cancer biology
Manyi Wei
acute megakaryoblastic leukemia
Shannon Maude
Immunotherapy for ALL
Lei Ding
myeloproliferative neoplasms, myelofibrosis
Jalpa Doshi
Equity in Access
Suzanne Lentzsch
Myeloma
Daniel Thomas
Myelofibrosis
Mark Hamilton
DLBCL and CAR-T
Kura Oncology
MLL leukemia, AML
Roberta Zappasodi
lymphoma, immunotherapy
Srividya Swaminathan
pediatric, immunotherapy
Pietro Genovese
transplant and AML
Jayna Mistry
aging and leukemias
Steven Horwitz
T-cell lymphomas
Brian Walker
smoldering myeloma, MGUS
Brian Dalton
DNA mutations and myeloid cancers
Steven Treon
Lymphomas and Waldenstrom's
Constellation Pharmaceuticals
myeloproliferative neoplasms
Alfred Garfall
myeloma immunotherapy
Kerry Rogers
CLL
Dren Bio
immunotherapy, cytotoxic lymphomas, LGLL
Constantine Mitsiades
CAR-T and CAR-NK immunotherapies
F. Lennie Wong
Equity in Access
Jeffrey Magee
pediatric AML
Steven Park
follicular lymphoma
Fahmin Basher
transplant and GvHD
Jing Fu
myeloma
Rajni Kumari
AML
Takeshi Sugio
T-cell lymphoma
Thomas LeBlanc
palliative care
Roland Walter
Antibody-based AML therapies
Taishi Yonezawa
AML
Bailee Kain
AML and African ancestry
Patrizia Mondello
IgM MGUS & Waldenstrom Macroglobulinemia
Oreofe Odejide
Equity in Access
Kirk Schultz
pediatric transplantation
Daisuke Nakada
preleukemia, leukemia
Yan Liu
MDS
Mark Dawson
B-ALL and CAR-T resistance
Stephen Oh
myeloproliferative neoplasms
Amin Sobh
Myeloma biology
Bingyi Chen
AML immunotherapy
John DiPersio
trispecific antibody for AML and MDS
Cailin Collins
Leukemia and pre-leukemia
Yibin Yang
Lymphoma
Lev Kats
myeloma and epigenetics
Carma Bylund
Equity in Access
Eric Padron
CMML
Richard Lock
T-ALL
Timothy Graubert
AML and MDS biology
Meng Li
Equity in Access
Adi Nagler
Bronchiolitis obliterans after transplant
Rong Lu
preleukemia, leukemia
Elliot Stieglitz
CMML
Sriram Sundaravel
AML stem cells
Armin Rashidi
gut bacteria and transplant success
Nicola Vannini
Aging and CAR-T success
Michael Savona
MDS and leukemia
Suman Paul
T cell cancers and immunotherapy
Caroline Arber
myeloma CAR-T
Catriona Jamieson
cancer stem cell biology
Qing Yi
Novel CAR-T
Enterome
vaccine, FL, MZL
Matteo Bellone
Smoldering multiple myeloma
Thomas Koehnke
leukemia
Coleman Lindsley
AML/MDS
Lucy Godley
preleukemia
Pooja Khandelwal
bone marrow transplantation
Caner Saygin
T-ALL
Jianguo Tao
Mantle Cell Lymphoma
Liran Shlush
pre-leukemia
Jessica Stewart
Epstein-barr virus and lymphomas
Luca Busino
DLBCL
Catherine Smith
leukemia
Markus Muschen
leukemia and lymphoma biology
Christine Zhang
AML
Sam Butterworth
CMML
Anthony Letai
improving CAR-T
Jaehyuk Choi
T-cell lymphoma
Venkata Lokesh Battula
immunotherapy and AML
Daniel Starczynowski
MDS and AML
Ana Vujovic
AML
Andrew Lane
BPDCN
Christopher Booth
BPDCN
Jennifer Woyach
CLL trials
Philippe Armand
follicular lymphoma
Omar Abdel-Wahab
Hairy cell leukemia
Siegfried Janz
Myeloma immunotherapy
Jonas Jutzi
myeloproliferative neoplasms
Logan Spector
childhood leukemia epidimiology
Sarah Tasian
pediatric leukemias
Madhav Dhodapkar
multiple myeloma immunotherapy
Robert Orlowski
(Smoldering) Multiple Myeloma
Teresa Palomero
Peripheral T-cell Lymphoma
Marc Seifert
Hairy cell leukemia
Keisuke Ito
blood cancer stem cells and MDS metabolism
Hong Wen
AML
Rachel Mersfelder
AMKL
Gaurav Goyal
Erdheim-Chester Disease
Michael Wang
Mantle Cell Lymphoma
Tyler Parsons
MPN and AML